Nayax (NYSE: NYAX) CEO acquires 235K shares via options
Rhea-AI Filing Summary
Nayax Ltd. (NYAX) reported that CEO, Co Founder & Chairman Yair Nechmad exercised stock options into ordinary shares on August 26, 2026. He exercised options covering 235,605 ordinary shares at an exercise price of $33.7079 per share (U.S. dollar amount reflecting a New Israeli Shekel–denominated grant). The options exercised were originally granted in 2022 and 2025 with expirations in 2027 and 2030, respectively. The filing does not state his total share holdings after these transactions.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 235,605 shares
Net Buy
8 txns
Insider
Nechmad Yair
Role
CEO, Co Founder & Chairman
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F2 | 75,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F2 | 75,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F2 | 70,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F2 | 15,605 | $0.00 | $0.00 |
| Exercise | Ordinary Shares F3, F4 | 75,000 | $33.7079 | $2.53M |
| Exercise | Ordinary Shares F3, F4 | 75,000 | $33.7079 | $2.53M |
| Exercise | Ordinary Shares F3, F4 | 70,000 | $33.7079 | $2.36M |
| Exercise | Ordinary Shares F3, F4 | 15,605 | $33.7079 | $526K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Ordinary Shares — 7,329,047 shares (Direct)
Footnotes (4)
- F1. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
- F2. The options reported herein were exercised on the date reported, and the shares acquired upon exercise are reported in Table I .
- F3. The shares were acquired upon the exercise of stock options
- F4. The exercise price is denominated in New Israeli Shekels. The U.S. dollar amount reported reflects the exchange rate on the grant date.
Key Figures
Options exercised: 235,605 shares
Exercise price: $33.7079 per share
Derivative transaction count: 4 transactions
+2 more
5 metrics
Options exercised
235,605 shares
Total underlying ordinary shares from four derivative exercises on August 26, 2026
Exercise price
$33.7079 per share
Exercise price for the stock options, denominated in New Israeli Shekels with U.S. dollar amount based on grant-date exchange rate
Derivative transaction count
4 transactions
Number of stock option exercises (code M) reported in derivative securities
Non-derivative acquisition count
4 transactions
Number of ordinary share acquisitions corresponding to option exercises on August 26, 2026
Option expiration dates
March 8, 2027; March 4, 2030
Expiration dates for the option series exercised
Key Terms
Stock Option (Right to Buy), Ordinary Shares, exercise price, New Israeli Shekels
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"The exercise price is denominated in New Israeli Shekels."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
New Israeli Shekels financial
"denominated in New Israeli Shekels. The U.S. dollar amount reported"
FAQ
What insider transaction did NYAX report for Yair Nechmad on August 26, 2026?
Nayax Ltd. (NYAX) reported that Yair Nechmad exercised stock options covering 235,605 ordinary shares on August 26, 2026, acquiring the same number of ordinary shares through option exercises rather than open-market purchases or sales.
What was the exercise price for Yair Nechmad’s NYAX stock options?
The reported exercise price for the options was $33.7079 per share, with a footnote stating that the exercise price is denominated in New Israeli Shekels and the U.S. dollar amount reflects the exchange rate on the grant date.
What are the grant and expiration dates of the NYAX options exercised by Yair Nechmad?
The options exercised on August 26, 2026 include grants with exercise dates of March 8, 2022 expiring on March 8, 2027, and grants with exercise dates of March 4, 2025 expiring on March 4, 2030.
Does the NYAX Form 4 indicate a Rule 10b5-1 trading plan for Yair Nechmad’s transactions?
The document-level Rule 10b5-1 checkbox is not checked (aff_10b5_one is false), and the footnotes do not state that these transactions were made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.